Stock Comparison
TEVA vs VTRS
Teva Pharma Industries Ltd ADR and Viatris Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$41.60B
$18.59B
P/E (TTM)
59.5
—
Forward P/E
17.2
6.6
Price/Sales
2.4
1.3
Price/Book
5.4
1.3
EV/EBITDA
20.9
11.8
Dividend Yield
—
2.99%
Profitability
Net Margin
9.02%
-2.04%
Operating Margin
13.19%
0.96%
Return on Equity
9.69%
-2.75%
Return on Assets
5.13%
2.67%
Growth (YoY)
Revenue Growth
-0.80%
4.90%
Earnings Growth
72.20%
-70.60%
Price & Risk
Beta
0.9
0.9
52-Week High
$36.74
$17.86
52-Week Low
$17.54
$9.24
Analyst Target
$41.20
$18.50
Compare TEVA and VTRS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.